Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Enterobacteriaceae”

418 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 418 results

Not applicableStudy completedNCT02709408
What this trial is testing

European Prospective Cohort Study on Enterobacteriaceae Showing Resistance to Carbapenems

Who this might be right for
Carbapenem Resistant Bacteria Infection
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 2,515
Not applicableStudy completedNCT03963297
What this trial is testing

Multicenter Evaluation of the Susceptibility of Enterobacteriaceae and Pseudomonas Aeruginosa to Ceftolozane/Tazobactam Combination

Who this might be right for
Antibiotic Resistant Strain
Fondation Hôpital Saint-Joseph 747
Testing effectiveness (Phase 2)Study completedNCT03479710
What this trial is testing

Fecal Microbiota Transplantation for CRE/VRE

Who this might be right for
Antimicrobial ResistanceColonization
Chinese University of Hong Kong 19
Testing effectiveness (Phase 2)WithdrawnNCT03643887
What this trial is testing

Phase II Trial of Fecal Microbiota Transplant (FMT) for VRE and CRE Patients

Who this might be right for
Clostridium Difficile Infection
University of Wisconsin, Madison
Post-approval studies (Phase 4)UnknownNCT02681263
What this trial is testing

Efficacy of Temocillin in Urinary Tract Infection Due to ESBL Producing and AmpC Hyperproducing Enterobacteriaceae

Who this might be right for
Urinary Tract Infections
University Hospital, Grenoble 25
Early research (Phase 1)Study completedNCT01509846
What this trial is testing

Safety Study of Inactivated Shigella Whole Cell Vaccine in Adults

Who this might be right for
Shigellosis
PATH 82
Not applicableUnknownNCT02367339
What this trial is testing

Assessment of the Prevalence of Extended-Spectrum Betalactamase Producing Enterobacteriaceae Among ICU Staff

Who this might be right for
Antibiotic ResistanceExtended-spectrum BetalactamaseEnterobacteriaceae+1 more
University Hospital, Clermont-Ferrand 100
Large-scale testing (Phase 3)Active Not RecruitingNCT06838195
What this trial is testing

Clinical Trial of the S. Flexneri-S. Sonnei Bivalent Conjugate Vaccine

Who this might be right for
DysenteryDysentery, Shigella
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 8,000
Not applicableStudy completedNCT03889067
What this trial is testing

Understanding How Salmonella Typhi Infects Humans (Bottlenecks)

Who this might be right for
Salmonella Typhi Infection
University of Oxford 11
Testing effectiveness (Phase 2)Study completedNCT01193907
What this trial is testing

Safety and Immunogenicity of Three Formulations of Vi-CRM197 Vaccine Against S. Typhi in Adults (18-40 Years Old)

Who this might be right for
Typhoid Fever
Novartis 88
Not applicableUnknownNCT06258551
What this trial is testing

Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients

Who this might be right for
Antimicrobial Drug ResistanceAntibiotic Resistant InfectionClostridium Difficile+5 more
The Methodist Hospital Research Institute 1,000
Not applicableStudy completedNCT02890901
What this trial is testing

Prognostic Factors of Escherichia Coli Bloodstream Infections: Severity Score and Therapeutic Implications

Who this might be right for
Escherichia Coli Bloodstream Infection
Assistance Publique - Hôpitaux de Paris 553
Not applicableStudy completedNCT00915213
What this trial is testing

Incidence of Antibiotic Resistant E.Coli in Patients Undergoing Repeat Prostate Biopsy

Who this might be right for
Bacterial Infection
University of California, Irvine 136
Not applicableEnrolling By InvitationNCT07039955
What this trial is testing

Effect of Daily Chlorhexidine Bathing and Antibiotic/PPI Stewardship on Prevention of CPE Transmission and Infection

Who this might be right for
Carbapenemase-Producing Enterobacteriaceae (CPE)Healthcare-Associated Infections (HAIs)
Chuncheon Sacred Heart Hospital 5,760
Testing effectiveness (Phase 2)Study completedNCT00485134
What this trial is testing

Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection

Who this might be right for
Shigellosis
U.S. Army Medical Research and Development Command 113
Not applicableEnded earlyNCT01820793
What this trial is testing

Efficacy and Pharmacokinetic/Pharmacodynamic Parameters of Cefoxitin in Women With Acute Pyelonephritis Without Severity Symptoms Due to Extended-spectrum β-lactamase Producing Escherichia Coli

Who this might be right for
Acute Pyelonephritis Without Severity Symptoms Due to ESBL-producing E.Coli
Assistance Publique - Hôpitaux de Paris 9
Post-approval studies (Phase 4)WithdrawnNCT01543347
What this trial is testing

Temocillin Use in Complicated Urinary Tract Infections Due to Extended Spectrum Beta-Lactamases (ESBL)/AmpC Enterobacteriaceae

Who this might be right for
Urinary Tract Infection
Belpharma s.a.
Large-scale testing (Phase 3)UnknownNCT03159078
What this trial is testing

Polymyxin B Monotherapy vs Combination Therapy in Critically Ill Patients With Multi-drug Resistant Pathogens

Who this might be right for
TraumaResistant InfectionCritical Illness
University of Puerto Rico 40
Early research (Phase 1)Study completedNCT02034500
What this trial is testing

Evaluate a New Shigella Sonnei Vaccine Administered Either by Intradermal, Intranasal or Intramuscular Route in Healthy Adults

Who this might be right for
Shigellosis
GSK Vaccines Institute For Global Health S.r.l. 52
Early research (Phase 1)Study completedNCT02052934
What this trial is testing

Safety of Sublingual dmLT for ETEC

Who this might be right for
Gastroenteritis Escherichia Coli
National Institute of Allergy and Infectious Diseases (NIAID) 80
Next Page